Cost-Effectiveness & Equitable Access to Vaccines in Ethiopia: Overview and Evidence Synthesis
2021
This article explores the gaps in vaccine coverage and the resulting burden of vaccine-preventable diseases (VPDs) among poorer households in Ethiopia, despite the introduction of new vaccines and improved access to immunization services. It provides an overview of vaccine economics in Ethiopia, examining cost-effectiveness analysis, the cost of illness related to VPDs, equitable vaccine access, and immunization financing. The paper highlights significant disparities in vaccine access based on geographic location, socioeconomic status, and maternal education. Poor households in Ethiopia face substantial out-of-pocket expenditures for VPDs, potentially leading to financial hardship. While financing for immunization services has seen modest enhancements in recent years before the onset of the COVID-19 pandemic, challenges persist. Economic evaluation studies suggest that immunization programs in Ethiopia could offer pro-poor benefits, providing health and financial risk protection particularly to the most economically vulnerable households.
Cost-Effectiveness & Equitable Access to Vaccines in Ethiopia: Overview and Evidence Synthesis
Source:
Memirie ST, Nigus M, Verguet S. Cost-Effectiveness and Equitable Access to Vaccines in Ethiopia: An Overview and Evidence Synthesis of the Published Literature. Journal of Global Health Reports 2021; 5: e2021008. https://doi.org/10.29392/001c.19354